SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '0SB'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTI_E_CCSE47_0 (GLUTATHIONES-TRANSFERASE) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 4 / 7 | THR A 504GLY A 454LEU A 456TYR A 459 | None0SB A 701 (-3.5A)NoneNone | 1.01A | 1gtiE-4f4pA:undetectable | 1gtiE-4f4pA:18.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M17_A_AQ4A999_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377ALA A 400LYS A 402GLU A 420LEU A 446GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.68A | 1m17A-4f4pA:34.8 | 1m17A-4f4pA:39.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MUO_A_ADNA1_1 (AURORA-RELATEDKINASE 1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 9 | LEU A 377GLY A 378VAL A 385ALA A 400ALA A 451LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-3.6A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 (-4.0A)0SB A 701 (-4.4A) | 0.94A | 1muoA-4f4pA:7.6 | 1muoA-4f4pA:26.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1T46_A_STIA3_1 (HOMO SAPIENS V-KITHARDY-ZUCKERMAN 4FELINE SARCOMA VIRALONCOGENE HOMOLOG) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402GLU A 420VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.88A | 1t46A-4f4pA:30.4 | 1t46A-4f4pA:35.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XBB_A_STIA1_1 (TYROSINE-PROTEINKINASE SYK) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 9 / 9 | LEU A 377VAL A 385ALA A 400MET A 448MET A 450ALA A 451GLY A 454PRO A 455LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 (-3.6A)0SB A 701 (-3.5A)0SB A 701 (-4.0A)0SB A 701 (-3.5A)0SB A 701 (-4.3A)0SB A 701 (-4.4A) | 0.32A | 1xbbA-4f4pA:42.4 | 1xbbA-4f4pA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2GQG_A_1N1A501_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377ALA A 400LYS A 402GLU A 420MET A 424VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.60A | 2gqgA-4f4pA:34.9 | 2gqgA-4f4pA:39.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2GQG_B_1N1B502_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420MET A 424VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.53A | 2gqgB-4f4pA:34.5 | 2gqgB-4f4pA:39.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HYY_B_STIB600_2 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 4 / 6 | LEU A 377LYS A 402VAL A 423VAL A 433 | 0SB A 701 ( 3.9A)0SB A 701 ( 4.8A)NoneNone | 0.82A | 2hyyB-4f4pA:30.7 | 2hyyB-4f4pA:40.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HYY_C_STIC600_2 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 4 / 6 | LEU A 377LYS A 402VAL A 423MET A 424 | 0SB A 701 ( 3.9A)0SB A 701 ( 4.8A)NoneNone | 0.76A | 2hyyC-4f4pA:30.7 | 2hyyC-4f4pA:40.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ITO_A_IREA2020_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377ALA A 400LYS A 402GLU A 420MET A 424LEU A 446GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.65A | 2itoA-4f4pA:32.5 | 2itoA-4f4pA:39.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ITY_A_IREA2020_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 11 / 12 | LEU A 377GLY A 378VAL A 385ALA A 400LYS A 402GLU A 420MET A 424LEU A 446GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-3.6A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.72A | 2ityA-4f4pA:32.9 | 2ityA-4f4pA:39.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ITZ_A_IREA2021_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 9 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402GLU A 420MET A 424GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.59A | 2itzA-4f4pA:32.6 | 2itzA-4f4pA:39.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OIQ_A_STIA1001_2 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 4 / 5 | LEU A 377VAL A 423LEU A 427ARG A 493 | 0SB A 701 ( 3.9A)NoneNoneSO4 A 702 (-3.0A) | 0.80A | 2oiqA-4f4pA:30.4 | 2oiqA-4f4pA:37.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XP2_A_VGHA9000_1 (TYROSINE-PROTEINKINASE RECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 9 | LEU A 377VAL A 385ALA A 400GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.50A | 2xp2A-4f4pA:31.6 | 2xp2A-4f4pA:32.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y6O_A_1N1A1892_1 (EPHRIN TYPE-ARECEPTOR 4) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | ALA A 400LYS A 402GLU A 420MET A 424GLY A 454LEU A 501SER A 511 | 0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.2A) | 0.70A | 2y6oA-4f4pA:26.9 | 2y6oA-4f4pA:35.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ZVA_A_1N1A513_1 (TYROSINE-PROTEINKINASE LYN) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377ALA A 400LYS A 402GLU A 420MET A 424VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.41A | 2zvaA-4f4pA:33.1 | 2zvaA-4f4pA:36.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AOX_A_EMHA901_1 (ALK TYROSINE KINASERECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 10 | LEU A 377ALA A 400LYS A 402VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)None0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.43A | 3aoxA-4f4pA:24.8 | 3aoxA-4f4pA:32.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3C7Q_A_XINA1172_1 (VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377GLY A 378ALA A 400LYS A 402VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-3.6A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)None0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.84A | 3c7qA-4f4pA:29.0 | 3c7qA-4f4pA:34.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS9_B_NILB600_2 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 5 / 9 | LEU A 377VAL A 385LYS A 402VAL A 433PHE A 490 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 ( 4.8A)NoneNone | 0.85A | 3cs9B-4f4pA:30.3 | 3cs9B-4f4pA:39.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS9_B_NILB600_2 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 5 / 9 | LEU A 377VAL A 385VAL A 433PHE A 490LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)NoneNone0SB A 701 (-4.4A) | 0.75A | 3cs9B-4f4pA:30.3 | 3cs9B-4f4pA:39.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS9_D_NILD600_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 5 / 12 | ALA A 400GLU A 420VAL A 423MET A 424GLY A 454 | 0SB A 701 (-3.3A)NoneNoneNone0SB A 701 (-3.5A) | 0.57A | 3cs9D-4f4pA:29.9 | 3cs9D-4f4pA:39.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G5D_A_1N1A1_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420MET A 424VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.56A | 3g5dA-4f4pA:32.1 | 3g5dA-4f4pA:37.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G5D_B_1N1B1_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 9 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402GLU A 420MET A 424VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.59A | 3g5dB-4f4pA:31.8 | 3g5dB-4f4pA:37.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GVU_A_STIA1001_1 (TYROSINE-PROTEINKINASE ABL2) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420MET A 424VAL A 433LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNoneNone0SB A 701 (-4.4A) | 0.79A | 3gvuA-4f4pA:30.0 | 3gvuA-4f4pA:39.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K54_A_1N1A1_1 (TYROSINE-PROTEINKINASE BTK) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 9 / 12 | LEU A 377ALA A 400LYS A 402GLU A 420MET A 424VAL A 433GLY A 454LEU A 501SER A 511 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.2A) | 0.60A | 3k54A-4f4pA:30.3 | 3k54A-4f4pA:35.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K5V_A_STIA2_2 (TYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 4 / 6 | LEU A 377LYS A 402VAL A 423VAL A 433 | 0SB A 701 ( 3.9A)0SB A 701 ( 4.8A)NoneNone | 0.75A | 3k5vA-4f4pA:29.3 | 3k5vA-4f4pA:40.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MIY_A_B49A1_1 (TYROSINE-PROTEINKINASE ITK/TSK) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 11 | ALA A 400LYS A 402GLY A 454LEU A 501SER A 511ASP A 512 | 0SB A 701 (-3.3A)0SB A 701 ( 4.8A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.2A)0SB A 701 (-3.9A) | 0.81A | 3miyA-4f4pA:32.1 | 3miyA-4f4pA:38.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MIY_A_B49A1_1 (TYROSINE-PROTEINKINASE ITK/TSK) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 11 | ALA A 400LYS A 402VAL A 433GLY A 454LEU A 501SER A 511 | 0SB A 701 (-3.3A)0SB A 701 ( 4.8A)None0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.2A) | 0.78A | 3miyA-4f4pA:32.1 | 3miyA-4f4pA:38.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MIY_B_B49B2_1 (TYROSINE-PROTEINKINASE ITK/TSK) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 5 / 9 | ALA A 400LYS A 402GLY A 454LEU A 501SER A 511 | 0SB A 701 (-3.3A)0SB A 701 ( 4.8A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.2A) | 0.72A | 3miyB-4f4pA:26.8 | 3miyB-4f4pA:38.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MS9_A_STIA1_1 (TYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420MET A 424LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNone0SB A 701 (-4.4A) | 0.91A | 3ms9A-4f4pA:30.0 | 3ms9A-4f4pA:40.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MS9_B_STIB1_1 (TYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420MET A 424GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 1.02A | 3ms9B-4f4pA:30.0 | 3ms9B-4f4pA:40.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MSS_A_STIA1_1 (TYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420MET A 424LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNone0SB A 701 (-4.4A) | 0.94A | 3mssA-4f4pA:30.1 | 3mssA-4f4pA:40.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MSS_C_STIC1_1 (TYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420MET A 424LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNone0SB A 701 (-4.4A) | 0.96A | 3mssC-4f4pA:30.1 | 3mssC-4f4pA:40.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MSS_D_STID1_1 (TYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 12 | LEU A 377ALA A 400GLU A 420MET A 424GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 1.02A | 3mssD-4f4pA:26.0 | 3mssD-4f4pA:40.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MSS_D_STID1_2 (TYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 4 / 6 | VAL A 385LYS A 402VAL A 423VAL A 433 | 0SB A 701 (-4.0A)0SB A 701 ( 4.8A)NoneNone | 0.73A | 3mssD-4f4pA:26.0 | 3mssD-4f4pA:40.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OCT_A_1N1A663_1 (TYROSINE-PROTEINKINASE BTK) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)None0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.56A | 3octA-4f4pA:29.5 | 3octA-4f4pA:38.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OEZ_A_STIA601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | VAL A 385ALA A 400GLU A 420MET A 424VAL A 433GLY A 454LEU A 501 | 0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.77A | 3oezA-4f4pA:30.0 | 3oezA-4f4pA:36.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OEZ_B_STIB601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | VAL A 385ALA A 400LYS A 402GLU A 420VAL A 423MET A 424LEU A 501 | 0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNoneNone0SB A 701 (-4.4A) | 0.70A | 3oezB-4f4pA:30.3 | 3oezB-4f4pA:36.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OXZ_A_0LIA1_1 (TYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 12 | ALA A 400GLU A 420MET A 424VAL A 433GLY A 454HIS A 492 | 0SB A 701 (-3.3A)NoneNoneNone0SB A 701 (-3.5A)None | 0.81A | 3oxzA-4f4pA:31.1 | 3oxzA-4f4pA:41.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3PYY_B_STIB4_1 (V-ABL ABELSON MURINELEUKEMIA VIRALONCOGENE HOMOLOG 1ISOFORM B VARIANT) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420MET A 424VAL A 433LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNoneNone0SB A 701 (-4.4A) | 0.85A | 3pyyB-4f4pA:30.7 | 3pyyB-4f4pA:40.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QLG_A_1N1A601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420MET A 424VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.48A | 3qlgA-4f4pA:30.6 | 3qlgA-4f4pA:36.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QLG_A_1N1A601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402GLU A 420MET A 424VAL A 433GLY A 454 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNoneNone0SB A 701 (-3.5A) | 0.64A | 3qlgA-4f4pA:30.6 | 3qlgA-4f4pA:36.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QLG_B_1N1B601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 9 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420MET A 424VAL A 433GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.67A | 3qlgB-4f4pA:25.6 | 3qlgB-4f4pA:36.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SXR_A_1N1A1_1 (CYTOPLASMICTYROSINE-PROTEINKINASE BMX) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400MET A 424VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.59A | 3sxrA-4f4pA:31.9 | 3sxrA-4f4pA:38.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SXR_B_1N1B2_1 (CYTOPLASMICTYROSINE-PROTEINKINASE BMX) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400MET A 424VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.59A | 3sxrB-4f4pA:31.5 | 3sxrB-4f4pA:38.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SXR_B_1N1B2_1 (CYTOPLASMICTYROSINE-PROTEINKINASE BMX) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400MET A 424VAL A 433GLY A 454SER A 511 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-3.2A) | 0.73A | 3sxrB-4f4pA:31.5 | 3sxrB-4f4pA:38.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UE4_B_DB8B601_1 (TYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400MET A 424VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.53A | 3ue4B-4f4pA:34.7 | 3ue4B-4f4pA:40.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UG2_A_IREA1_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400LEU A 446MET A 448GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)None0SB A 701 (-3.6A)0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.65A | 3ug2A-4f4pA:34.3 | 3ug2A-4f4pA:39.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UG2_A_IREA1_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402LEU A 446MET A 448GLY A 454 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)None0SB A 701 (-3.6A)0SB A 701 (-3.5A) | 0.68A | 3ug2A-4f4pA:34.3 | 3ug2A-4f4pA:39.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ZBF_A_VGHA3000_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ROS) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 5 / 12 | LEU A 377ALA A 400GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.43A | 3zbfA-4f4pA:27.8 | 3zbfA-4f4pA:33.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4AG8_A_AXIA2000_1 (VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402GLU A 420VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.86A | 4ag8A-4f4pA:30.6 | 4ag8A-4f4pA:33.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4AGC_A_AXIA2000_1 (VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402GLU A 420GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)None0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.89A | 4agcA-4f4pA:30.0 | 4agcA-4f4pA:34.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4AGD_A_B49A2000_1 (VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 11 | LEU A 377ALA A 400LYS A 402VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)None0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.83A | 4agdA-4f4pA:29.4 | 4agdA-4f4pA:34.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ANQ_A_VGHA9000_1 (ALK TYROSINE KINASERECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 9 | LEU A 377VAL A 385ALA A 400GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.50A | 4anqA-4f4pA:31.5 | 4anqA-4f4pA:31.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ANS_A_VGHA9000_1 (ALK TYROSINE KINASERECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 9 | LEU A 377VAL A 385ALA A 400MET A 448GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 (-3.6A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.65A | 4ansA-4f4pA:31.4 | 4ansA-4f4pA:31.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I22_A_IREA9001_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 10 / 12 | LEU A 377GLY A 378VAL A 385ALA A 400LYS A 402LEU A 446MET A 448GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-3.6A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)None0SB A 701 (-3.6A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.81A | 4i22A-4f4pA:28.8 | 4i22A-4f4pA:39.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KS8_A_B49A701_1 (SERINE/THREONINE-PROTEIN KINASE PAK 6) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 10 | ALA A 400VAL A 433MET A 448GLY A 454LEU A 501SER A 511ASP A 512 | 0SB A 701 (-3.3A)None0SB A 701 (-3.6A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.2A)0SB A 701 (-3.9A) | 0.82A | 4ks8A-4f4pA:26.2 | 4ks8A-4f4pA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MKC_A_4MKA1503_1 (ALK TYROSINE KINASERECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.53A | 4mkcA-4f4pA:31.1 | 4mkcA-4f4pA:29.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MXO_A_DB8A601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420MET A 424VAL A 433GLY A 454ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNoneNone0SB A 701 (-3.5A)0SB A 701 (-3.9A) | 0.54A | 4mxoA-4f4pA:32.8 | 4mxoA-4f4pA:36.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MXO_A_DB8A601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402GLU A 420MET A 424GLY A 454ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-3.9A) | 0.69A | 4mxoA-4f4pA:32.8 | 4mxoA-4f4pA:36.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MXO_B_DB8B601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420VAL A 433GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.55A | 4mxoB-4f4pA:32.4 | 4mxoB-4f4pA:36.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MXO_B_DB8B601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402GLU A 420GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)None0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.78A | 4mxoB-4f4pA:32.4 | 4mxoB-4f4pA:36.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MXX_A_DB8A601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377ALA A 400LYS A 402GLU A 420MET A 424VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.68A | 4mxxA-4f4pA:32.5 | 4mxxA-4f4pA:36.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MXX_B_DB8B601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)None0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.58A | 4mxxB-4f4pA:25.9 | 4mxxB-4f4pA:36.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MXY_A_DB8A601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 9 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420VAL A 433MET A 448GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNone0SB A 701 (-3.6A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.54A | 4mxyA-4f4pA:33.2 | 4mxyA-4f4pA:36.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MXY_B_DB8B601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 9 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420VAL A 433MET A 448GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNone0SB A 701 (-3.6A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.77A | 4mxyB-4f4pA:27.9 | 4mxyB-4f4pA:36.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MXZ_A_DB8A601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 9 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420VAL A 433MET A 448GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNone0SB A 701 (-3.6A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.54A | 4mxzA-4f4pA:33.2 | 4mxzA-4f4pA:36.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MXZ_B_DB8B601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 9 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420VAL A 433MET A 448GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNone0SB A 701 (-3.6A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.77A | 4mxzB-4f4pA:27.9 | 4mxzB-4f4pA:36.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O0S_A_ADNA500_1 (AURORA KINASE A) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 11 | LEU A 377GLY A 378VAL A 385ALA A 400LYS A 402ASN A 499LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-3.6A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)0SB A 701 (-3.8A)0SB A 701 (-4.4A) | 0.90A | 4o0sA-4f4pA:26.3 | 4o0sA-4f4pA:26.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OTW_A_DB8A1101_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-3) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385LYS A 402VAL A 433GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 ( 4.8A)None0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.81A | 4otwA-4f4pA:27.1 | 4otwA-4f4pA:32.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QRC_A_0LIA802_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 4) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 5 / 12 | ALA A 400GLU A 420MET A 424LEU A 485ARG A 493 | 0SB A 701 (-3.3A)NoneNoneNoneSO4 A 702 (-3.0A) | 0.97A | 4qrcA-4f4pA:29.3 | 4qrcA-4f4pA:37.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4R7I_A_STIA1001_1 (MACROPHAGECOLONY-STIMULATINGFACTOR 1 RECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 12 | VAL A 385ALA A 400LYS A 402GLU A 420MET A 424LEU A 501 | 0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNone0SB A 701 (-4.4A) | 0.73A | 4r7iA-4f4pA:29.4 | 4r7iA-4f4pA:31.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4TYJ_A_0LIA801_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 4) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 12 | ALA A 400GLU A 420MET A 424ALA A 451HIS A 492LEU A 501 | 0SB A 701 (-3.3A)NoneNone0SB A 701 (-4.0A)None0SB A 701 (-4.4A) | 0.78A | 4tyjA-4f4pA:30.2 | 4tyjA-4f4pA:37.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U0I_A_0LIA1001_1 (MAST/STEM CELLGROWTH FACTORRECEPTORKIT,MAST/STEM CELLGROWTH FACTORRECEPTOR KIT) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 10 | LEU A 377VAL A 385GLU A 420LEU A 427ILE A 432VAL A 433ILE A 510 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)NoneNoneNoneNoneNone | 0.83A | 4u0iA-4f4pA:30.1 | 4u0iA-4f4pA:35.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4V01_A_0LIA1776_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 5 / 12 | ALA A 400GLU A 420ALA A 451LEU A 485HIS A 492 | 0SB A 701 (-3.3A)None0SB A 701 (-4.0A)NoneNone | 0.84A | 4v01A-4f4pA:29.1 | 4v01A-4f4pA:36.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4V01_A_0LIA1776_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 5 / 12 | ALA A 400GLU A 420MET A 424ALA A 451LEU A 485 | 0SB A 701 (-3.3A)NoneNone0SB A 701 (-4.0A)None | 0.87A | 4v01A-4f4pA:29.1 | 4v01A-4f4pA:36.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4V01_B_0LIB1770_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 12 | ALA A 400GLU A 420MET A 424ALA A 451LEU A 485HIS A 492 | 0SB A 701 (-3.3A)NoneNone0SB A 701 (-4.0A)NoneNone | 0.85A | 4v01B-4f4pA:29.4 | 4v01B-4f4pA:36.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4V04_A_0LIA1772_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 12 | VAL A 385ALA A 400GLU A 420ALA A 451HIS A 492GLY A 514 | 0SB A 701 (-4.0A)0SB A 701 (-3.3A)None0SB A 701 (-4.0A)NoneNone | 1.32A | 4v04A-4f4pA:25.9 | 4v04A-4f4pA:36.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4V04_B_0LIB1771_2 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 5 / 12 | ALA A 400GLU A 420ALA A 451LEU A 485HIS A 492 | 0SB A 701 (-3.3A)None0SB A 701 (-4.0A)NoneNone | 0.86A | 4v04B-4f4pA:29.4 | 4v04B-4f4pA:36.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WBO_B_ANWB601_0 (RHODOPSIN KINASE) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 5 / 8 | LEU A 377ALA A 400MET A 448LEU A 501SER A 511 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)0SB A 701 (-3.6A)0SB A 701 (-4.4A)0SB A 701 (-3.2A) | 0.66A | 4wboB-4f4pA:23.5 | 4wboB-4f4pA:20.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WBO_C_ANWC601_0 (RHODOPSIN KINASE) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 4 / 6 | LEU A 377ALA A 400MET A 448LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)0SB A 701 (-3.6A)0SB A 701 (-4.4A) | 0.67A | 4wboC-4f4pA:23.8 | 4wboC-4f4pA:20.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WKQ_A_IREA1101_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377ALA A 400LYS A 402GLU A 420MET A 424LEU A 446GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.62A | 4wkqA-4f4pA:34.8 | 4wkqA-4f4pA:39.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XEY_A_1N1A601_1 (TYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402MET A 424VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.58A | 4xeyA-4f4pA:35.4 | 4xeyA-4f4pA:30.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XEY_B_1N1B601_1 (TYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402MET A 424GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)None0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.59A | 4xeyB-4f4pA:35.2 | 4xeyB-4f4pA:30.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XEY_B_1N1B601_1 (TYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)None0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.44A | 4xeyB-4f4pA:35.2 | 4xeyB-4f4pA:30.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XLI_A_1N1A601_1 (NON-SPECIFICPROTEIN-TYROSINEKINASE) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377ALA A 400GLU A 420MET A 424VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)NoneNoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.49A | 4xliA-4f4pA:35.8 | 4xliA-4f4pA:41.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XLI_B_1N1B600_1 (NON-SPECIFICPROTEIN-TYROSINEKINASE) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377ALA A 400LYS A 402GLU A 420MET A 424VAL A 433GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.57A | 4xliB-4f4pA:35.5 | 4xliB-4f4pA:41.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AAA_A_VGHA9000_1 (ALK TYROSINE KINASERECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 9 | LEU A 377VAL A 385ALA A 400GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.45A | 5aaaA-4f4pA:31.8 | 5aaaA-4f4pA:32.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AAB_A_VGHA9000_1 (ALK TYROSINE KINASERECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 10 | LEU A 377VAL A 385ALA A 400LYS A 402GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.68A | 5aabA-4f4pA:31.7 | 5aabA-4f4pA:32.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AAC_A_VGHA9000_1 (ALK TYROSINE KINASERECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 10 | LEU A 377VAL A 385ALA A 400GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.56A | 5aacA-4f4pA:24.3 | 5aacA-4f4pA:32.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5BVW_A_1N1A1009_1 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402GLU A 420MET A 424GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.89A | 5bvwA-4f4pA:28.3 | 5bvwA-4f4pA:32.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H2U_A_1N1A501_1 (PROTEIN-TYROSINEKINASE 6) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 5 / 12 | LEU A 377VAL A 385ALA A 400GLY A 454LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 (-3.5A)0SB A 701 (-4.4A) | 0.41A | 5h2uA-4f4pA:29.5 | 5h2uA-4f4pA:38.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H2U_B_1N1B501_1 (PROTEIN-TYROSINEKINASE 6) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 12 | LEU A 377VAL A 385ALA A 400GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.65A | 5h2uB-4f4pA:29.5 | 5h2uB-4f4pA:38.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H2U_D_1N1D504_1 (PROTEIN-TYROSINEKINASE 6) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 12 | LEU A 377VAL A 385ALA A 400GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.60A | 5h2uD-4f4pA:29.4 | 5h2uD-4f4pA:38.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5I9Y_A_1N1A1001_1 (EPHRIN TYPE-ARECEPTOR 2) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | ALA A 400LYS A 402GLU A 420MET A 424GLY A 454LEU A 501SER A 511 | 0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.2A) | 0.65A | 5i9yA-4f4pA:31.7 | 5i9yA-4f4pA:36.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IGV_A_ZITA404_1 (MACROLIDE2'-PHOSPHOTRANSFERASE II) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 5 / 12 | TYR A 539GLU A 420SER A 511ILE A 510MET A 482 | NoneNone0SB A 701 (-3.2A)NoneNone | 1.26A | 5igvA-4f4pA:8.0 | 5igvA-4f4pA:22.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MO4_A_NILA601_2 (TYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 5 / 12 | ALA A 400VAL A 423MET A 424VAL A 433LEU A 501 | 0SB A 701 (-3.3A)NoneNoneNone0SB A 701 (-4.4A) | 0.74A | 5mo4A-4f4pA:24.2 | 5mo4A-4f4pA:26.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N3H_A_NCAA401_0 (CAMP-DEPENDENTPROTEIN KINASECATALYTIC SUBUNITALPHA) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 10 | LEU A 377VAL A 385ALA A 400VAL A 433MET A 448LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)None0SB A 701 (-3.6A)0SB A 701 (-4.4A) | 0.69A | 5n3hA-4f4pA:23.6 | 5n3hA-4f4pA:22.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5P9I_A_1E8A701_1 (TYROSINE-PROTEINKINASE BTK) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | VAL A 385ALA A 400LYS A 402GLY A 454LEU A 501SER A 511PHE A 513 | 0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.2A)None | 1.06A | 5p9iA-4f4pA:30.2 | 5p9iA-4f4pA:37.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5U63_A_ACTA406_0 (THIOREDOXINREDUCTASE) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 3 / 3 | HIS A 492SER A 511ARG A 498 | None0SB A 701 (-3.2A)None | 0.97A | 5u63A-4f4pA:undetectable | 5u63A-4f4pA:20.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VCV_A_1N1A404_1 (MEMBRANE-ASSOCIATEDTYROSINE- ANDTHREONINE-SPECIFICCDC2-INHIBITORYKINASE) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 12 | LEU A 377ALA A 400LYS A 402GLU A 420VAL A 433LEU A 446 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNoneNone | 0.94A | 5vcvA-4f4pA:24.8 | 5vcvA-4f4pA:22.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VCY_A_DB8A401_1 (MEMBRANE-ASSOCIATEDTYROSINE- ANDTHREONINE-SPECIFICCDC2-INHIBITORYKINASE) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402GLU A 420LEU A 446 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNone | 0.81A | 5vcyA-4f4pA:24.8 | 5vcyA-4f4pA:22.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5W5V_A_ANWA701_0 (SERINE/THREONINE-PROTEIN KINASE TBK1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 5 / 9 | LEU A 377ALA A 400VAL A 433MET A 448GLY A 454 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)None0SB A 701 (-3.6A)0SB A 701 (-3.5A) | 0.68A | 5w5vA-4f4pA:13.4 | 5w5vA-4f4pA:16.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XV7_A_EMHA705_1 (SERINE-ARGININE (SR)PROTEIN KINASE 1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 5 / 12 | LEU A 377GLY A 378VAL A 385ALA A 400GLY A 454 | 0SB A 701 ( 3.9A)0SB A 701 (-3.6A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 (-3.5A) | 0.56A | 5xv7A-4f4pA:23.1 | 5xv7A-4f4pA:12.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y7Z_B_IREB401_0 (CYCLIN-G-ASSOCIATEDKINASE) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377ALA A 400GLU A 420LEU A 446GLY A 454LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-3.3A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.78A | 5y7zB-4f4pA:17.3 | 5y7zB-4f4pA:13.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YU9_A_1E8A1101_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | LEU A 377GLY A 378VAL A 385ALA A 400LYS A 402LEU A 446LEU A 501ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-3.6A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)None0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.92A | 5yu9A-4f4pA:25.5 | 5yu9A-4f4pA:45.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YU9_A_1E8A1101_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377GLY A 378VAL A 385ALA A 400LYS A 402MET A 448ASP A 512 | 0SB A 701 ( 3.9A)0SB A 701 (-3.6A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)0SB A 701 (-3.6A)0SB A 701 (-3.9A) | 1.07A | 5yu9A-4f4pA:25.5 | 5yu9A-4f4pA:45.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YU9_B_1E8B1101_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | GLY A 378VAL A 385ALA A 400LYS A 402LEU A 446LEU A 501ASP A 512 | 0SB A 701 (-3.6A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)None0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.97A | 5yu9B-4f4pA:25.5 | 5yu9B-4f4pA:45.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YU9_C_1E8C1101_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 12 | VAL A 385ALA A 400LYS A 402LEU A 446GLY A 454ASP A 512 | 0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)None0SB A 701 (-3.5A)0SB A 701 (-3.9A) | 1.06A | 5yu9C-4f4pA:25.7 | 5yu9C-4f4pA:45.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YU9_D_1E8D1101_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 6 / 12 | VAL A 385ALA A 400LYS A 402GLY A 454LEU A 501ASP A 512 | 0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.9A) | 0.86A | 5yu9D-4f4pA:28.3 | 5yu9D-4f4pA:45.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZV2_B_LEVB801_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402GLU A 420MET A 424ALA A 451 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNone0SB A 701 (-4.0A) | 0.79A | 5zv2B-4f4pA:29.2 | 5zv2B-4f4pA:15.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6C2M_C_SUEC1203_1 (NS3 PROTEASE) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 5 / 9 | GLY A 454ILE A 432LYS A 509ARG A 498ASP A 494 | 0SB A 701 (-3.5A)NoneNoneNoneNone | 1.34A | 6c2mC-4f4pA:undetectable | 6c2mC-4f4pA:13.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6FNM_A_1N1A1001_1 (-) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 8 / 12 | VAL A 385ALA A 400LYS A 402GLU A 420MET A 424GLY A 454LEU A 501SER A 511 | 0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNone0SB A 701 (-3.5A)0SB A 701 (-4.4A)0SB A 701 (-3.2A) | 0.88A | 6fnmA-4f4pA:32.6 | 6fnmA-4f4pA:36.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HD6_B_STIB601_0 (TYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400GLU A 420MET A 424VAL A 433LEU A 501 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)NoneNoneNone0SB A 701 (-4.4A) | 0.91A | 6hd6B-4f4pA:24.7 | 6hd6B-4f4pA:13.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HD6_B_STIB601_0 (TYROSINE-PROTEINKINASE ABL1) |
4f4p | TYROSINE-PROTEINKINASE SYK (Homosapiens) | 7 / 12 | LEU A 377VAL A 385ALA A 400LYS A 402GLU A 420MET A 424VAL A 433 | 0SB A 701 ( 3.9A)0SB A 701 (-4.0A)0SB A 701 (-3.3A)0SB A 701 ( 4.8A)NoneNoneNone | 0.79A | 6hd6B-4f4pA:24.7 | 6hd6B-4f4pA:13.04 |